Product
AZD6563
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase I, Open-label, Randomized, Active-Controlled Study in Adults to Characterize the Safety and Immunogenicity of AZD9838 and AZD6563 Vaccine (ARTEMIS-C)Status: Active (not recruiting), Estimated PCD: 2024-05-06